151 related articles for article (PubMed ID: 37663815)
1. HM-chromanone isolated from
Park JE; Han JS
Toxicol Res (Camb); 2023 Aug; 12(4):648-657. PubMed ID: 37663815
[TBL] [Abstract][Full Text] [Related]
2. HM-Chromanone, a Major Homoisoflavonoid in
Park JE; Han JS
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145191
[TBL] [Abstract][Full Text] [Related]
3. HM-chromanone attenuates TNF-α-mediated inflammation and insulin resistance by controlling JNK activation and NF-κB pathway in 3T3-L1 adipocytes.
Park JE; Kang E; Han JS
Eur J Pharmacol; 2022 Apr; 921():174884. PubMed ID: 35288193
[TBL] [Abstract][Full Text] [Related]
4. HM-chromanone suppresses hepatic glucose production via activation of AMP-activated protein kinase in HepG2 cell.
Park JE; Han JS
Eur J Pharmacol; 2022 Aug; 928():175108. PubMed ID: 35718128
[TBL] [Abstract][Full Text] [Related]
5. HM-chromanone from Portulaca oleracea L. inhibits protein tyrosine phosphatase 1B and mitigates glucose production in insulin-resistant HepG2 cells.
Lim HJ; Park JE; Han JS
Fitoterapia; 2023 Jun; 167():105512. PubMed ID: 37080256
[TBL] [Abstract][Full Text] [Related]
6. A bioactive component of
Park JE; Han JS
Toxicol Res (Camb); 2022 Oct; 11(5):774-783. PubMed ID: 36337245
[TBL] [Abstract][Full Text] [Related]
7. HM-chromanone, a component of Portulaca oleracea L., stimulates glucose uptake and glycogen synthesis in skeletal muscle cell.
Park JE; Seo Y; Han JS
Phytomedicine; 2021 Mar; 83():153473. PubMed ID: 33513558
[TBL] [Abstract][Full Text] [Related]
8. HM-chromanone reverses the blockade of insulin signaling induced by high glucose levels in human HepG2 cells.
Park JE; Han JS
Eur J Pharmacol; 2022 Dec; 937():175358. PubMed ID: 36332682
[TBL] [Abstract][Full Text] [Related]
9. HM-Chromanone Isolated from
Park JE; Seo Y; Han JS
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30769910
[TBL] [Abstract][Full Text] [Related]
10. HM-chromanone alleviates hyperglycemia and inflammation in mice with endotoxin-induced insulin resistance.
Lim HJ; Park JE; Han JS
Toxicol Res (Camb); 2023 Aug; 12(4):665-674. PubMed ID: 37663814
[TBL] [Abstract][Full Text] [Related]
11. (
Kang E; Park JE; Seo Y; Han JS
Immunopharmacol Immunotoxicol; 2021 Oct; 43(5):611-621. PubMed ID: 34388059
[TBL] [Abstract][Full Text] [Related]
12. HM-chromanone inhibits adipogenesis by regulating adipogenic transcription factors and AMPK in 3T3-L1 adipocytes.
Je JY; Park JE; Seo Y; Han JS
Eur J Pharmacol; 2021 Feb; 892():173689. PubMed ID: 33127360
[TBL] [Abstract][Full Text] [Related]
13. CtBP2 ameliorates palmitate-induced insulin resistance in HepG2 cells through ROS mediated JNK pathway.
Liu P; Shi L; Cang X; Huang J; Wu X; Yan J; Chen L; Cui S; Ye X
Gen Comp Endocrinol; 2017 Jun; 247():66-73. PubMed ID: 28111233
[TBL] [Abstract][Full Text] [Related]
14. A new chromanone isolated from Portulaca oleracea L. increases glucose uptake by stimulating GLUT4 translocation to the plasma membrane in 3T3-L1 adipocytes.
Park JE; Park JY; Seo Y; Han JS
Int J Biol Macromol; 2019 Feb; 123():26-34. PubMed ID: 30389528
[TBL] [Abstract][Full Text] [Related]
15. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
[TBL] [Abstract][Full Text] [Related]
16. PINK1 alleviates palmitate induced insulin resistance in HepG2 cells by suppressing ROS mediated MAPK pathways.
Cang X; Wang X; Liu P; Wu X; Yan J; Chen J; Wu G; Jin Y; Xu F; Su J; Wan C; Wang X
Biochem Biophys Res Commun; 2016 Sep; 478(1):431-438. PubMed ID: 27423393
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
Dong Y; Gao G; Fan H; Li S; Li X; Liu W
PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
[TBL] [Abstract][Full Text] [Related]
18. HMC Ameliorates Hyperglycemia via Acting PI3K/AKT Pathway and Improving FOXO1 Pathway in ob/ob Mice.
Yoo J; Park JE; Han JS
Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432173
[TBL] [Abstract][Full Text] [Related]
19. Pterostilbene reverses palmitic acid mediated insulin resistance in HepG2 cells by reducing oxidative stress and triglyceride accumulation.
Malik SA; Acharya JD; Mehendale NK; Kamat SS; Ghaskadbi SS
Free Radic Res; 2019 Jul; 53(7):815-827. PubMed ID: 31223033
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells.
Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D
Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
